MedPath

Rotator Interval and Intra-articular Corticosteroid Injection for Frozen Shoulder

Not Applicable
Completed
Conditions
Adhesive Capsulitis
Interventions
Registration Number
NCT00840229
Lead Sponsor
Oslo University Hospital
Brief Summary

The purpose of this study is to compare ultrasound guided capsular corticosteroid injection into the rotator interval/anterior capsule and the GH joint with ultrasound guided corticosteroid injection into the GH joint only. Both methods will be compared with placebo injections.

Primary outcome measure: pain reduction at week 6 Secondary outcome measures: improvement of function (SPADI, Life quality, ROM).

0-hypothesis: no difference between the methods.

The investigators want to find out if the clinical effect of the combined capsular and intra-articular injections are better than placebo and better that intra-articular injections

Detailed Description

3 groups, 50 patients in each, follow-up visits after 3, 6, 12 and 26 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
122
Inclusion Criteria
  • Pain and stiffness in one shoulder 1 - 6 months
  • Restriction of passive ROM; >= 30 degrees in two or more planes compared to other shoulder
Exclusion Criteria
  • Systemic inflammatory disease
  • Corticosteroid treatment last 3 months
  • Poorly controlled Diabetes mellitus
  • Pregnancy
  • Contraindications/allergy to corticosteroids and/or Lidocaine
  • Severe infections
  • Osteoarthritis of the shoulder
  • Fractures of the shoulder
  • Rotator cuff pathology causing pain or disability
  • Fibromyalgia
  • Not able to understand Norwegian

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1 capsular & intra-articularTriamcinolone hexacetonidecorticosteroid injection (Triamcinolone) in capsule/rotator interval and intra-articular
2 intra-articularTriamcinolone hexacetonidecorticosteroid injection (Triamcinolone) intra-articular placebo injection (Lidocaine) in capsule
3 placeboTriamcinolone hexacetonideplacebo injections (Lidocaine) in capsule and intra-articular
Primary Outcome Measures
NameTimeMethod
Pain reduction2-3 years
Secondary Outcome Measures
NameTimeMethod
Function (ROM, SPADI), Life quality2-3 years

Trial Locations

Locations (1)

Vestfold Hospitalt Trust, Clinic Physical Medicine and Rehabilitation

🇳🇴

Stavern, Norway

© Copyright 2025. All Rights Reserved by MedPath